DIRECTSYNC SURGICAL

(Formerly Evoke Medical)

 
Pelvic X-Ray

OUR STORY

Changing the Rules of the Bone Healing Game


Smart implants are going to change the way spine and orthopedic surgeons treat their patients. Imagine, though, if you could power implantable sensors AND enhance bone healing with just human motion - no batteries or external stimulators required. 

With a unique biomaterial born out of the research lab and an experienced team behind it, DirectSync Surgical is redefining the way orthopedic and spinal implantable devices are researched, designed, and developed.


We view things differently...We don't see the implant as a foreign object with the sole purpose of stabilizing or restoring motion. Instead, we view the implant as an integral part of the natural biochemical and biomechanical responses of the body postoperatively.  We seek to mimic the bodies natural osteoinductive healing mechanisms via our implant designs, while providing important post-operative implant data to inform patients and providers.

 

OUR MISSION

DirectSync Surgical is pioneering a new generation of human powered smart implants that enhance the body's natural ability to heal & provides unprecedented post-operative implant data to the physician and their patients.

 

PLATFORM TECHNOLOGY

We leverage the human body's mechanical biofeedback system to design fully integrated smart implants that sense load and electrically stimulate bone growth at the primary site of implantation - no batteries or external stimulators required


Our proprietary technology mimics the natural healing properties of bone by producing a small pulse of DC electrical stimulation in sync with each step the patient takes. This core innovation has applications in multiple load-bearing orthopedic implants.

platformtech.png
 
1516169051336_edited.jpg

Zygmunt Porada, MBA, B.S.

CEO

Leighton.png

Leighton LaPierre, M.S.

COO & Co-Founder

2205305_Portrait Day April 2022-1362-2-Edit for web_edited_edited.jpg

Lisa Friis, Ph.D.

CTO & Co-Founder

paul.png

Paul Arnold, MD

CMO & Co-Founder

edk_edited.jpg

Ember Krech, Ph.D.

Lead R&D Engineer

 

INVEST IN THE FUTURE OF SPINE AND ORTHOPEDIC SURGERY

We are actively seeking a seed round investment to further advance our platform technology.

Key Accomplishments:

  • ​$1.75M in non-dilutive NIH SBIR funding

  • 2 pre-clinical animal studies 

  • Issued foundational IP & other pending IP

  • Completed FDA pre-submission meeting

Thanks for submitting!

 

Check us out on RYOrtho THE PITCH!

 

No direct clinical claims are being made at this time.  All devices/technologies presented here are investigational & any formal claims will be approved by the FDA prior to placing the device into interstate commerce.